BioSpace News Archive

Pharm Country

Delcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4) - December 16, 2022

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that the Company granted an equity award, previously approved by the Company’s Compensation Committee, as a material inducement to employment for one individual.

December 16, 2022
·
2 min read
Jalon Therapeutics Raises Nearly 2 Million Euros to Develop a Disruptive Approach in Oncology

After a seed funding of €625,000 raised at the beginning of 2022 from Family offices and Business Angels, Jalon Therapeutics won the Innov’Up PIA call for an amount of €450,000 and issued convertible bonds subscribed by BPI France on November 29, 2022 for an amount of €450,000.

December 16, 2022
·
3 min read
Business

Sectra’s six-month interim report 2022/2023: Highest order bookings in Sectra’s history

International medical imaging IT and cybersecurity company Sectra Sectra reported increased sales and its order bookings grew.

December 16, 2022
·
5 min read
CES 2023: OMRON Healthcare Introducing Initiatives to Advance Its Vision of “Going for Zero” -- Elimination of Heart Attack and Stroke

These initiatives include the innovative heart health devices such as Complete, the upper-arm blood pressure monitor with built-in ECG technology, and their global remote patient-monitoring services.

December 16, 2022
·
3 min read
Biotech Bay

Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb

Evotec SE announced that the Company has achieved further significant progress within its neuroscience collaboration with Bristol Myers Squibb.

December 16, 2022
·
4 min read
RevoluGen Announces Distribution Agreement with BioEntist for Fire Monkey HMW-DNA Extraction Products in Thailand

RevoluGen Ltd. is pleased to announce it has entered into a non-exclusive distribution agreement with BioEntist of Thailand for the distribution of its Fire Monkey™ High Molecular Weight -DNA extraction product range.

December 16, 2022
·
5 min read
BioMidwest

CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE

Centene Corporation (NYSE: CNC) today will host its investor day to outline its 2023 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value.

December 16, 2022
·
12 min read
Business

Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Inc. today announced a clinical trial collaboration with Roche to evaluate the triple combination of Adagene’s ADG126 with Roche’s atezolizumab and bevacizumab in first-line treatment of advanced hepatocellular carcinoma (HCC; liver cancer).

December 16, 2022
·
6 min read
Deals

Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field

Reference is made to the announcement issued earlier today about the completion of a private placement of subordinated convertible bonds.

December 16, 2022
·
8 min read
Deals

BioStem Technologies Announces Up-Listing to the OTCQB Venture Market

BioStem Technologies Inc. is pleased to announce that its common shares have been successfully up-listed from the OTC Pink Sheet Open Market to the OTCQB Venture Market (the “ OTCQB ”) by the OTC Markets Group Inc.

December 16, 2022
·
4 min read